arrow
J

Jourik A. Gietema

University Medical Centre Groningen
H指数:70
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment

程序性死亡配体1(PD-L1)PET/CT成像评估阿特珠治疗期间肿瘤饱和度

2026-09-100
OAAI
Improving the Understanding of Late Effects of Testicular Cancer in Adolescent and Young Adult Survivors: TRANSCEND-XR

改善青少年和年轻成年睾丸癌幸存者晚期效应的理解:TRANSCEND-XR

2026-05-250
OA
Effects of self-monitoring physical activity with a smartphone application combined with physiotherapy coaching in patients with cancer: a randomised controlled trial (SMART-COACH trial)

使用智能手机应用程序结合物理治疗教练对癌症患者进行自我监测身体活动的效果:一项随机对照试验(SMART-COACH试验)

2025-07-150
OAAI
Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer Guideline Harmonization Group

儿童、青少年和年轻成人癌症幸存者的代谢综合征:国际儿童癌症晚期效应指南协调小组的监测建议

2025-03-190
PRE
Identification of genes associated with testicular germ cell tumor susceptibility through a transcriptome-wide association study

通过全转录组关联研究鉴定与睾丸生殖细胞肿瘤易感性相关的基因

2025-02-010
OAAI
Characteristics and palliative management of patients with cisplatin-refractory germ cell tumours: A Global Germ Cell Cancer Collaborative Group (G3) retrospective registry study

顺铂耐药性生殖细胞肿瘤患者的特点与姑息管理:全球生殖细胞癌协作组(G3)回顾性登记研究

2024-09-010
PRE
Debio 0123+carboplatin (CP) for patients (pts) with advanced solid tumors: Safety, preliminary efficacy and determination of recommended phase II dose (RP2D)

Debio 0123+顺铂(CP)用于晚期实体瘤患者的治疗:安全性、初步疗效及推荐II期剂量的确定(RP2D)

2024-09-010
PRE
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium

畸胎瘤对转移性非精原细胞性生殖细胞癌患者生存概率的影响: IGCCCG更新联盟的结果

2024-05-010
PRE
Impact of food and high gastric pH on the bioavailability of the WEE1 inhibitor Debio 0123 assessed in a phase 1 dose escalation study
2024-04-050
PRE
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol

Cemiplimab在局部晚期或转移性皮肤鳞状细胞癌中的应用: 来自药物访问方案的前瞻性真实数据

2024-04-014
OA
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN
2024-04-013
OAAI
Evaluation of Senescence and Its Prevention in Doxorubicin-Induced Cardiotoxicity Using Dynamic Engineered Heart Tissues
2023-06-019
OA
Whole-body CDS+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial

癌症免疫治疗之前和期间的全身CDS T细胞可视化: 1/2期试验

2022-12-0554
OAAI